Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ATOVAQUONE USP (D144 PROCESS), with a corresponding US DMF Number 31142.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 02, 2017, and payment made on January 05, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II